Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo.

Recombinant adenovirus (Ad) has shown great promise in gene therapy. Artificial envelopment of adenovirus within lipid bilayers has previously been shown to decrease the immunogenicity and hepatic affinity of naked Ad in vivo. Unfortunately, this also resulted in a significant reduction of gene expression, which we attributed to poor endosomal release of the Ad from its artificial lipid envelope. In this work, we explored the artificial envelopment of Ad within pH-sensitive DOPE:CHEMS bilayers and characterized this vector by TEM, AFM, dot blot, dynamic light scattering and zeta potential measurements. The artificially enveloped viral vectors exhibited good stability at physiological pH but immediately collapsed and released naked Ad virions at pH 5.5. Intracellular trafficking using confocal laser scanning microscopy (CLSM) revealed that Cy3-labelled Ad enveloped in DOPE:CHEMS bilayers exhibited the characteristic Ad distribution within the cytoplasm that led to virion accumulation around the nuclear membrane, indicating endosomal release of Ad. We obtained equivalent levels of gene expression as those of naked Ad in a series of CAR-positive (CAR+) and CAR-negative (CAR-) cell lines. This suggested that the mechanism of infection for the artificially enveloped Ad remained dependent on the presence of CAR receptors. Finally, the pH-sensitive enveloped Ad were injected intratumorally in human cervical carcinoma xenograft-bearing nude mice, also illustrating their capacity for efficient in vivo marker gene expression. This study is a step forward toward the engineering of functional, artificially enveloped adenovirus vectors for gene transfer applications.

[1]  F. Szoka,et al.  Chemical approaches to triggerable lipid vesicles for drug and gene delivery. , 2003, Accounts of chemical research.

[2]  D. McDonald,et al.  Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells , 1999, Gene Therapy.

[3]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[4]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[5]  K. Al‐Jamal,et al.  Nanoengineering artificial lipid envelopes around adenovirus by self-assembly. , 2008, ACS nano.

[6]  Andrew D. Miller,et al.  Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. , 2005, Chemical Society reviews.

[7]  Luis Carrasco.  Entry of animal viruses and macromolecules into cells , 1994, FEBS letters.

[8]  R. Crystal,et al.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. , 1999, The Journal of clinical investigation.

[9]  A. Jones,et al.  Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. , 2005, Advanced drug delivery reviews.

[10]  J. Lehn,et al.  Novel cationic lipids incorporating an acid-sensitive acylhydrazone linker: synthesis and transfection properties. , 2004, Journal of medicinal chemistry.

[11]  M. Zignani,et al.  Current status of pH-sensitive liposomes in drug delivery. , 2000, Progress in lipid research.

[12]  Kostas Kostarelos,et al.  Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[14]  D. Thompson,et al.  Formation of Plasmid-Based Transfection Complexes with an Acid-Labile Cationic Lipid: Characterization of in Vitro and in Vivo Gene Transfer , 2002, Pharmaceutical Research.

[15]  D. Curiel,et al.  Current developments in adenovirus-based cancer gene therapy. , 2006, Future oncology.

[16]  S. Han,et al.  Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivo , 2008, Experimental & Molecular Medicine.

[17]  David H. Thompson,et al.  Cytosolic drug delivery using pH- and light-sensitive liposomes. , 1999, Advanced drug delivery reviews.

[18]  Zinnia P. Parra-Guillen,et al.  Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview , 2010, Pharmaceutical Research.

[19]  M. Barry,et al.  Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. , 2006, Virology.

[20]  James M. Wilson,et al.  “Stealth” Adenoviruses Blunt Cell-Mediated and Humoral Immune Responses against the Virus and Allow for Significant Gene Expression upon Readministration in the Lung , 2001, Journal of Virology.

[21]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[22]  F. Szoka,et al.  pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. , 1984, Biochemistry.

[23]  M. Rots,et al.  A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. , 2003, Virology.

[24]  I. Kovesdi,et al.  Reducing the Native Tropism of Adenovirus Vectors Requires Removal of both CAR and Integrin Interactions , 2001, Journal of Virology.

[25]  N. Hackett,et al.  Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. , 1998, Human gene therapy.

[26]  M. C. Lima,et al.  DNA pre-condensation with an amino acid-based cationic amphiphile. A viable approach for liposome-based gene delivery , 2008, Molecular membrane biology.